Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
news
Presentation of Founder & CEO at ICI Meeting 2018, Tel Aviv, Israel
Development of post-myocardial infarction-induced heart failure in closed-chest coronary occlusion/reperfusion models in landrace pigs and Göttingen minipigs: feasibility and translational values, presentation by Founder & CEO
news
35th Annual Meeting of the European Section of the ISHR
35th Annual Meeting of the European Section of the ISHR, Amsterdam, The Netherlands
news
5th International Symposium, New Frontiers in Cardiovascular Research
Pharmahungary Group scientific management team has attended the 5th International Symposium, New Frontiers in Cardiovascular Research in Sapporo, Japan
news
It is with great sadness that we announce the passing of Jacques van Rooyen, PhD
It is with great sadness that we announce the passing of Jacques van Rooyen, PhD